Comments

Lexeo Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Lexeo Therapeutics (LXEO) operate in?

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LXEONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$7.79

-0.63-7.42%

Last update: 12:39 PM

Q3 2025 Earnings were released on Wed Nov 5th, before the market open

Lexeo Therapeutics (LXEO) Forecast

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Lexeo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LXEO | Benzinga

Explore Lexeo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXEO.

Open	$8.30
Close	-
Volume / Avg.	1.24M / 969.86K
Day Range	$7.66 - $8.36
52 Wk Range	1.45 - 11.72
Market Cap	$568.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	10.72%
Days to Cover	4.66

Recent News

James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

FDA Outlines Process To Speed Up Rare Disease Therapy Approvals

FDA launches Rare Disease Evidence Principles to guide therapy reviews, offering new pathways for approval while raising questions on development impact.

Vandana Singh

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.30
Close	-
Volume / Avg.	1.24M / 969.86K
Day Range	$7.66 - $8.36
52 Wk Range	1.45 - 11.72
Market Cap	$568.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	10.72%
Days to Cover	4.66

About Lexeo Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healt...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lexeo Therapeutics (LXEO) stock?

You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.

View our list of the best stock brokerages

Who are Lexeo Therapeutics (LXEO) competitors?

Other companies in Lexeo Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), KalVista Pharmaceuticals (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).

What is the forecast, or price target, for Lexeo Therapeutics (LXEO) stock?

Lexeo Therapeutics has a consensus price target of $19.30.

What is the current price for Lexeo Therapeutics (LXEO)?

The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $7.795 last updated November 7, 2025 at 12:39 PM EST.

Does Lexeo Therapeutics (LXEO) pay a dividend?

There are no upcoming dividends for Lexeo Therapeutics.

When is Lexeo Therapeutics (NASDAQ:LXEO) reporting earnings?

Lexeo Therapeutics’s Q3 earnings are confirmed for Wednesday, November 5, 2025.

Is Lexeo Therapeutics (LXEO) going to split?

There is no upcoming split for Lexeo Therapeutics.

What sector and industry does Lexeo Therapeutics (LXEO) operate in?

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.